Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Desarrollo de un tratamiento tópico (colirio) para la retinopatía diabética basado en la señalización de la vía del GLP-1 (DTS15/00151).

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 18000
Reference: INT16/00204
Duration: 01/01/2017 - 31/12/2017

Desenvolupament d'un tractament tòpic (col·liri) per a la retinopatia basat en la senyalització de la via del GLP-1

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 45600
Reference: 2016 FI_B 00808
Duration: 01/03/2016 - 28/02/2019

La Diabetis com accelerador de deteriorament cognitiu i malaltia d¿ Alzheimer: abordatge integral i adherència al tractament (DIALCAT)

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 74566.35
Reference: SLT002/16/00366
Duration: 01/04/2017 - 31/12/2019

Opioid receptor: a key player in blood retinal barrier breakdown in diabetic retina

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: European Foundation for the Study of Diabetes
Funding: 19800
Reference: RPE_EFSDSANOFI2015
Duration: 01/07/2015 - 30/09/2016

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Yassin Belahnech Pujol

Yassin Belahnech Pujol

Main researcher
Cardiovascular Diseases
Read more
Sergio Huertas Torres

Sergio Huertas Torres

Research technician
Transfusional Medicine
Read more
Toni Soriano Colomé

Toni Soriano Colomé

Research technician
Cardiovascular Diseases
Read more
Jessica  Aguilera  Garcia

Jessica Aguilera Garcia

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.